http://blog.roodo.com/breast_ca/ 關於晚期乳癌 zh-tw Roodo Blog System All Rights Reserved http://blog.roodo.com/breast_ca/archives/9600219.html http://blog.roodo.com/breast_ca/archives/9600219.html 常見癌症名詞解說 Fri, 31 Jul 2009 16:55:50 +0800 http://blog.roodo.com/breast_ca/archives/9594821.html http://blog.roodo.com/breast_ca/archives/9594821.html 常見癌症名詞解說 Thu, 30 Jul 2009 17:53:06 +0800 Capecitabine in Combination with Novel Targeted Agents in the Management of Metastatic Breast Cancer: Underlying Rationale and Results of Clinical Trials
The Oncologist, Vol. 12, No. 4, 375-389, April 2007
]]> http://blog.roodo.com/breast_ca/archives/9588759.html http://blog.roodo.com/breast_ca/archives/9588759.html 晚期乳癌電子報 Wed, 29 Jul 2009 23:05:51 +0800 Green tea and the prevention of breast cancer: a case-control study
Carcinogenesis 2007 28(5):1074-1078
（這是西澳大學與浙江大學合作的研究） ]]> http://blog.roodo.com/breast_ca/archives/9588719.html http://blog.roodo.com/breast_ca/archives/9588719.html 晚期乳癌電子報 Wed, 29 Jul 2009 23:03:09 +0800 Results from a Phase III, randomized, double-blind, placebo-controlled study of darbepoetin alfa for the treatment of anemia in patients not receiving chemotherapy or radiotherapy

2007 AACR Annual Meeting ]]> http://blog.roodo.com/breast_ca/archives/9588689.html http://blog.roodo.com/breast_ca/archives/9588689.html 晚期乳癌電子報 Wed, 29 Jul 2009 23:01:53 +0800 Phase II trial of pegylated liposomal doxorubicin (Caelyx) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer
Acta Oncologica, Volume 46,Issue 2 2007 , pages 208 - 213 ]]> http://blog.roodo.com/breast_ca/archives/9588681.html http://blog.roodo.com/breast_ca/archives/9588681.html 晚期乳癌電子報 Wed, 29 Jul 2009 23:00:58 +0800 Managing taxane toxicities
Maurie Markman
Support Care Cancer (2003) 11:144–147 ]]> http://blog.roodo.com/breast_ca/archives/9588669.html http://blog.roodo.com/breast_ca/archives/9588669.html 晚期乳癌電子報 Wed, 29 Jul 2009 22:34:36 +0800 April 6, 2007
http://www.mc.vanderbilt.edu/reporter/index.html?ID=5454 ]]> http://blog.roodo.com/breast_ca/archives/9588555.html http://blog.roodo.com/breast_ca/archives/9588555.html 晚期乳癌電子報 Wed, 29 Jul 2009 22:32:00 +0800 針對HER2的治療：小分子HER-2酪胺酸激脢抑制劑

Breast Cancer Research 2007, 9:205 ]]> http://blog.roodo.com/breast_ca/archives/9588533.html http://blog.roodo.com/breast_ca/archives/9588533.html 晚期乳癌電子報 Wed, 29 Jul 2009 22:23:55 +0800
Pazopanib: A Novel Multitargeted Tyrosine Kinase Inhibitor
Guru Sonpavde and Thomas E. Hutson
Current Oncology Reports 2007, 9:115-119 ]]> http://blog.roodo.com/breast_ca/archives/9587061.html http://blog.roodo.com/breast_ca/archives/9587061.html 晚期乳癌電子報 Wed, 29 Jul 2009 21:00:37 +0800
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

Volume 8, Issue 3 , March 2007, Pages 219-225 ]]> http://blog.roodo.com/breast_ca/archives/9587055.html http://blog.roodo.com/breast_ca/archives/9587055.html 晚期乳癌電子報 Wed, 29 Jul 2009 20:59:30 +0800 The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers
P. Kelly Marcom, Claudine Isaacs, Lyndsay Harris, Zee Wang Wong, Aruna Kommarreddy, Nellie Novielli, Gretchen Mann, Yu Tao and Matthew J. Ellis
Breast Cancer Research and Treatment Volume 102, Number 1 / March, 2007 Pages 43-49 ]]> http://blog.roodo.com/breast_ca/archives/9587053.html http://blog.roodo.com/breast_ca/archives/9587053.html 晚期乳癌電子報 Wed, 29 Jul 2009 20:58:31 +0800 Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy
British Journal of Cancer (2006) 95, 1161-1166. ]]> http://blog.roodo.com/breast_ca/archives/9587051.html http://blog.roodo.com/breast_ca/archives/9587051.html 晚期乳癌電子報 Wed, 29 Jul 2009 20:57:35 +0800 Gemcitabine–Oxaliplatin Combination in Heavily Pretreated Metastatic Breast Cancer: A Pilot Study on 43 Patients
Volume 13 Issue 2 Page 165 - March/April 2007 ]]> http://blog.roodo.com/breast_ca/archives/9587047.html http://blog.roodo.com/breast_ca/archives/9587047.html 晚期乳癌電子報 Wed, 29 Jul 2009 20:55:43 +0800 The Oncologist, Vol. 12, No. 2, 152-155, February 2007;
doi:10.1634/theoncologist.12-2-152
Schellens, J. H.M. ]]> http://blog.roodo.com/breast_ca/archives/9587043.html http://blog.roodo.com/breast_ca/archives/9587043.html 晚期乳癌電子報 Wed, 29 Jul 2009 20:51:46 +0800 不管先前是否接受過雙磷酸鹽類藥物治療，ibandronate都可以減低病人的疼痛
[1076] Pain reduction with ibandronate is achieved regardless of prior bisphosphonate treatment.

2.
以15分或60分之時間經靜脈注射ibandronate對於腎臟的安全性
[1078] Renal safety of intravenous ibandronate 6mg infused over 15 or 60 minutes in patients with breast cancer and bone metastases. ]]> http://blog.roodo.com/breast_ca/archives/9587031.html http://blog.roodo.com/breast_ca/archives/9587031.html 晚期乳癌電子報 Wed, 29 Jul 2009 20:47:36 +0800 併用Iressa與docetaxel治療轉移乳癌病人
[1093] A randomized phase II trial with gefitinib and docetaxel in metastatic breast cancer: an evaluation of the treatment regimen and the factors associated with toxicity.
2.
併用Avastin以及與白蛋白結合之紫杉醇（Abraxane）治療轉移乳癌病人
[1095] Bevacizumab (avastin) and albumin bound paclitaxel (abraxane) treatment in metastatic breast cancer. ]]> http://blog.roodo.com/breast_ca/archives/9587023.html http://blog.roodo.com/breast_ca/archives/9587023.html 晚期乳癌電子報 Wed, 29 Jul 2009 20:44:34 +0800 以lapatinib作為罹患過度表現ErbB2之晚期或轉移乳癌併的第一線治療
[1090] Updated biomarker results from a phase II randomized study of lapatinib as first-line treatment for patients with ErbB2-amplified advanced or metastatic breast cancer.

2.
Lapatinib治療晚期或轉移乳癌病人的第二期試驗
[1091] Phase II clinical study of lapatinib (GW572016) in patients with advanced
or metastatic breast cancer. ]]> http://blog.roodo.com/breast_ca/archives/9587013.html http://blog.roodo.com/breast_ca/archives/9587013.html 晚期乳癌電子報 Wed, 29 Jul 2009 20:41:34 +0800 併用截瘤達與Avastin作為轉移乳癌病人第一線治療
[2068] Capecitabine plus bevacizumab in first line metastatic breast cancer: an interim safety and efficacy report of the first phase of xeloda plus avastin 1st line metastatic breast cancer trial.
2.
使用正子造影掃描評估罹患HER2陽性之轉移乳癌病人以lapatinib治療的效果
[1089] Evaluation of response to lapatinib in patients with HER2-positive metastatic breast cancer using FDG-PET. ]]> http://blog.roodo.com/breast_ca/archives/9586999.html http://blog.roodo.com/breast_ca/archives/9586999.html 晚期乳癌電子報 Wed, 29 Jul 2009 20:39:36 +0800 Herceptin 與 KOS-953治療Her2陽性乳癌病人
[1102] Phase 2 trial of trastuzumab (T) and KOS-953 (17-AAG) in patients with Her2-positive breast cancer: preliminary results.
2.
截瘤達與vinnorelbine在罹患轉移乳癌的老年病人作為第一線治療：第二期試驗
[6089] Capecitabine (C) and vinorelbine (V) in elderly patients (pts.) with metastatic breast cancer (MBC) as 1st line treatment: a prospective multicentre phase II study of the NOGGO breast cancer study group. ]]> http://blog.roodo.com/breast_ca/archives/9586987.html http://blog.roodo.com/breast_ca/archives/9586987.html 晚期乳癌電子報 Wed, 29 Jul 2009 20:34:27 +0800